JPH0148755B2 - - Google Patents
Info
- Publication number
- JPH0148755B2 JPH0148755B2 JP11369285A JP11369285A JPH0148755B2 JP H0148755 B2 JPH0148755 B2 JP H0148755B2 JP 11369285 A JP11369285 A JP 11369285A JP 11369285 A JP11369285 A JP 11369285A JP H0148755 B2 JPH0148755 B2 JP H0148755B2
- Authority
- JP
- Japan
- Prior art keywords
- dna
- sequence
- coli
- ptp63
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108020004414 DNA Proteins 0.000 claims description 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 22
- 239000013612 plasmid Substances 0.000 claims description 19
- 241000588724 Escherichia coli Species 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 11
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 claims description 10
- 229960001082 trimethoprim Drugs 0.000 claims description 10
- 102000053602 DNA Human genes 0.000 claims description 8
- 108091008146 restriction endonucleases Proteins 0.000 claims description 7
- 238000010367 cloning Methods 0.000 claims description 6
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims description 6
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims description 6
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 6
- 229930024421 Adenine Natural products 0.000 claims description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 3
- 229960000643 adenine Drugs 0.000 claims description 3
- 229940104302 cytosine Drugs 0.000 claims description 3
- 229940113082 thymine Drugs 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims 1
- 229960000723 ampicillin Drugs 0.000 claims 1
- 108010022394 Threonine synthase Proteins 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 14
- 238000000034 method Methods 0.000 description 8
- 238000013519 translation Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 102000004419 dihydrofolate reductase Human genes 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000013600 plasmid vector Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- -1 sulfur drugs Chemical compound 0.000 description 3
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 229960001931 ampicillin sodium Drugs 0.000 description 2
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- 108010052418 (N-(2-((4-((2-((4-(9-acridinylamino)phenyl)amino)-2-oxoethyl)amino)-4-oxobutyl)amino)-1-(1H-imidazol-4-ylmethyl)-1-oxoethyl)-6-(((-2-aminoethyl)amino)methyl)-2-pyridinecarboxamidato) iron(1+) Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108700003860 Bacterial Genes Proteins 0.000 description 1
- 102100021391 Cationic amino acid transporter 3 Human genes 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091006230 SLC7A3 Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000007169 ligase reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11369285A JPS61271990A (ja) | 1985-05-27 | 1985-05-27 | 改造ジヒドロ葉酸還元酵素遺伝子を含む特定ｄｎａ配列 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11369285A JPS61271990A (ja) | 1985-05-27 | 1985-05-27 | 改造ジヒドロ葉酸還元酵素遺伝子を含む特定ｄｎａ配列 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61271990A JPS61271990A (ja) | 1986-12-02 |
| JPH0148755B2 true JPH0148755B2 (enrdf_load_html_response) | 1989-10-20 |
Family
ID=14618765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11369285A Granted JPS61271990A (ja) | 1985-05-27 | 1985-05-27 | 改造ジヒドロ葉酸還元酵素遺伝子を含む特定ｄｎａ配列 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61271990A (enrdf_load_html_response) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940001265B1 (ko) * | 1988-12-29 | 1994-02-18 | 닛뽕 제온 가부시끼가이샤 | 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스 |
-
1985
- 1985-05-27 JP JP11369285A patent/JPS61271990A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61271990A (ja) | 1986-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Perret et al. | Relaxation of a transfer RNA specificity by removal of modified nucleotides | |
| Gardan et al. | Expression of therocDEFOperon Involved in Arginine Catabolism inBacillus subtilis | |
| JPH02478A (ja) | 部分的合成遺伝子の発現によるペプチドの製法 | |
| Yang et al. | Cloning and nucleotide sequence of the Escherichia coli cytidine deaminase (ccd) gene | |
| JPH06315379A (ja) | 血栓溶解剤 | |
| JPH0670772A (ja) | Ｔ７ｄｎａポリメラーゼ | |
| Perego et al. | Isolation and sequence of the spoOE gene: its role in initiation of sporulation in Bacillus subtills | |
| JPH0148755B2 (enrdf_load_html_response) | ||
| JP3822006B2 (ja) | シチジン５’−ジリン酸コリンの製造法 | |
| JPS60156388A (ja) | Ｄνａおよびその用途 | |
| JP2612687B2 (ja) | シクロマルトデキストリングルカノトランスフエラーゼ活性を有するポリペプチド | |
| JPH07108225B2 (ja) | Ｄ−アミノ酸オキシダ−ゼ遺伝子 | |
| JP2002528059A (ja) | 抗微生物剤の製造及び使用 | |
| JPH0148756B2 (enrdf_load_html_response) | ||
| JP2612684B2 (ja) | シクロマルトデキストリングルカノトランスフエラーゼ遺伝子を含む組換えｄｎａを導入した形質転換微生物とその利用 | |
| JPH0822223B2 (ja) | ＰｖｕＩ制限エンドヌクレアーゼの製造方法 | |
| JPH0364112B2 (enrdf_load_html_response) | ||
| JP2002051781A (ja) | デオキシヌクレオシドの酵素的製造法 | |
| JP2946579B2 (ja) | ハイブリッドプロモーター | |
| Holmes | RNA recognition and cleavage by iron (II)-bleomycin | |
| Burton | A study of the molecular mechanism of the attenuation response in the threonine operon of Escherichia coli by synthesis of mutant attenuators | |
| JP2579603B2 (ja) | マウスインターロイキン−２をコードする遺伝子を含むｄｎａ断片，該ｄｎａ断片を有する組換えベクターおよび該ベクターを保持する形質転換体 | |
| JPH0394685A (ja) | アスパラギン酸ラセマーゼをコードするｄｎａ | |
| JPH0148754B2 (enrdf_load_html_response) | ||
| JPH044882A (ja) | ヌクレオシド・ホスホリラーゼをコードするｄｎａ断片 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |